614 related articles for article (PubMed ID: 33652763)
1. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
[TBL] [Abstract][Full Text] [Related]
2. The Effectiveness of Synbiotic Preparation Containing
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
[TBL] [Abstract][Full Text] [Related]
3. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live
Srivastava S; Basak U; Naghibi M; Vijayakumar V; Parihar R; Patel J; Jadon PS; Pandit A; Dargad RR; Khanna S; Kumar S; Day R
Gut Microbes; 2024; 16(1):2338322. PubMed ID: 38630015
[TBL] [Abstract][Full Text] [Related]
7.
Martoni CJ; Srivastava S; Leyer GJ
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019158
[TBL] [Abstract][Full Text] [Related]
8. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study.
Sisson G; Ayis S; Sherwood RA; Bjarnason I
Aliment Pharmacol Ther; 2014 Jul; 40(1):51-62. PubMed ID: 24815298
[TBL] [Abstract][Full Text] [Related]
10. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.
Lorenzo-Zúñiga V; Llop E; Suárez C; Alvarez B; Abreu L; Espadaler J; Serra J
World J Gastroenterol; 2014 Jul; 20(26):8709-16. PubMed ID: 25024629
[TBL] [Abstract][Full Text] [Related]
11. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
[TBL] [Abstract][Full Text] [Related]
12. The Efficacy and Safety of Single-Strain Probiotic Formulations Containing
Skrzydło-Radomańska B; Prozorow-Król B; Kurzeja-Mirosław A; Cichoż-Lach H; Laskowska K; Majsiak E; Bierła JB; Agnieszka S; Cukrowska B
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510953
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
Whorwell PJ; Altringer L; Morel J; Bond Y; Charbonneau D; O'Mahony L; Kiely B; Shanahan F; Quigley EM
Am J Gastroenterol; 2006 Jul; 101(7):1581-90. PubMed ID: 16863564
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of
Lewis ED; Antony JM; Crowley DC; Piano A; Bhardwaj R; Tompkins TA; Evans M
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326347
[TBL] [Abstract][Full Text] [Related]
15. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
Pinto-Sanchez MI; Hall GB; Ghajar K; Nardelli A; Bolino C; Lau JT; Martin FP; Cominetti O; Welsh C; Rieder A; Traynor J; Gregory C; De Palma G; Pigrau M; Ford AC; Macri J; Berger B; Bergonzelli G; Surette MG; Collins SM; Moayyedi P; Bercik P
Gastroenterology; 2017 Aug; 153(2):448-459.e8. PubMed ID: 28483500
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Probiotic Escherichia coli Nissle 1917 in Patients with Irritable Bowel Syndrome: a Double Blind Placebo-controlled Randomized Trial.
Faghihi AH; Agah S; Masoudi M; Ghafoori SM; Eshraghi A
Acta Med Indones; 2015 Jul; 47(3):201-8. PubMed ID: 26586385
[TBL] [Abstract][Full Text] [Related]
17. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
Shanshal SA; Alsaaty MH; Al-Qazaz H; Al-Zidan RN
Ceska Slov Farm; 2024; 72(5):233-241. PubMed ID: 38195431
[TBL] [Abstract][Full Text] [Related]
18. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
Shanshal SA; Alsaaty MH; Al-Qazaz H; Al-Zidan RN
Ceska Slov Farm; 2024; 73(1):233-241. PubMed ID: 38185646
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients-A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial.
Sommermeyer H; Chmielowiec K; Bernatek M; Olszewski P; Kopczynski J; Piątek J
Nutrients; 2024 May; 16(10):. PubMed ID: 38794741
[TBL] [Abstract][Full Text] [Related]
20. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Andresen V; Gschossmann J; Layer P
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
